SELLAS Life Sciences Group, Inc. (SLS)

3.94 +0.48 (+13.87%) USD  |  NASDAQ  |  Jan 12, 11:18
More

SELLAS Life Sciences Group Normalized Basic EPS (Quarterly)

Normalized Basic EPS (Quarterly) Chart

View Normalized Basic EPS (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Basic EPS (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Basic EPS (Quarterly) Range, Past 5 Years

View Normalized Basic EPS (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Basic EPS (Quarterly) Benchmarks

View Normalized Basic EPS (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade